I am interested in designing mobile biosensors for detecting infections and sepsis. These biosensors take advantage of the outstanding physical properties of nanomaterials in order to detect proteins and pathogens with great sensitivity. Paper substrates ensure that the biosensors are portable and single-use for an easy implementation in clinical environments. I am also interested in using smartphones to detect the signals generated by these biosensors. This not only circumvents the requirement of additional instrumentation but also provides new possibilities for the early diagnosis and continuous monitoring of patients.
Dr. de la Rica completed his PhD in the field of biosensors at the National Center for Microelectronics in Barcelona, Spain. Upon graduation he immediately started working at the City University of New York. It was there that he expanded his research experience in the field of bionanotechnology. He pioneered new approaches in nanolithography and bio-inspired synthesis of nanomaterials by drawing from his previous work experience with biosensors. He then moved to Holland to work at the University of Twente where he integrated concepts in supramolecular chemistry with bionanotechnology applications. While there he obtained a Marie Curie Fellowship that allowed him to fund his research independently at Imperial College London. There, he designed ultrasensitive biosensors, peptide templates for nanoparticle growth and new bio-enabled nanofabrication approaches.
In October 2013 he became a Lecturer in Bionanotechnology at the University of Strathclyde. At Strathclyde he fabricated a new generation of bioengineered supraparticles for applications in health care and biomedicine. In 2016 he was awarded a prestigious Ramón y Cajal Award that allowed him to move his lab to the University of the Balearic Islands. In 2018 he became the Technology Coordinator of the Multidisciplinary Sepsis Group at IdiSBa. In 2019 he was awarded a competitive Radix Fellowship for developing biosensors based on augmented reality technology for improving sepsis care.